Back

Prospective Meta-Analysis of SGLT2 Inhibitor Randomized Trials in COVID-19

28 August 2023 (17:10 - 17:20)
Organised by: Logo
Congress Presentation Part of: HOT LINE 9 Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

8 More presentations in this session

Presentation thumbnail
RIGHT: Prolongation of anticoagulation after Primary PCI
Associate Professor Y. Yan (Beijing, CN)
Slides Video
Presentation thumbnail
Discussant review - RIGHT
Professor P. Vranckx (Hasselt, BE)
Slides Video
Presentation thumbnail
Panel discussion - RIGHT
Presentation thumbnail
ONCO DVT Study; Optimal duration of anticoagulation therapy for isolated distal deep vein thrombosis in patients with cancer study
Doctor Y. Yamashita (Kyoto, JP)
Slides Video
Presentation thumbnail
Discussant review - ONCO DVT
Doctor T. Lopez Fernandez (Madrid, ES)
Slides Video

Access the full session

Session thumbnail
HOT LINE 9
Video

The Event

Event poster

ESC Congress 2023

28 August 2023 17:10 CET
You may be interested in
thumbnail
Congress Presentation
Discussant review - Prospective Meta-Analysis of SGLT2 Inhibitor Randomized Trials in COVID-19
thumbnail
Congress Session
HOT LINE 9
thumbnail
Congress Presentation
Safety and efficacy of early initiation of sodium-glucose co-transporter inhibitors 2 in patients hospitalized for acute heart failure: a meta-analysis of randomized controlled trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources